tiprankstipranks
Teleflex Inc (TFX)
NYSE:TFX
US Market
Holding TFX?
Track your performance easily

Teleflex (TFX) Earnings Dates, Call Summary & Reports

391 Followers

Earnings Data

Report Date
Feb 20, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
3.86
Last Year’s EPS
3.38
Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Nov 01, 2018
|
% Change Since: -22.13%
|
Next Earnings Date:Aug 02, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with several positive highlights, such as revenue growth in key segments and successful acquisition performance, but also highlighted challenges in OEM revenue, UroLift growth, and a higher tax rate. Despite these challenges, the company showed strong cash flow and improved gross margins.
Company Guidance
During the Teleflex Q3 2024 earnings call, the company provided several financial updates and adjusted its guidance for the year. Revenue for the quarter was $764.4 million, registering a 2.4% year-over-year increase on a GAAP basis and 2.2% on an adjusted constant currency basis, slightly missing the earlier guidance range of $765 million to $770 million due to unexpected softness in the OEM business. The adjusted earnings per share (EPS) was $3.49, a 4.1% decrease from the prior year but higher than expectations due to strong margin performance. Gross margin improved by 140 basis points to 60.8%, and operating margin increased by 10 basis points to 27.3%. The company updated its 2024 revenue guidance to reflect adjusted constant currency growth of 3.5% to 4%, down from the previous 4.25% to 5.25%, with reported revenue growth now expected at 2.9% to 3.4%. Additionally, the EPS guidance was raised to a range of $13.90 to $14.20, reflecting the performance in Q3. The company also addressed challenges and opportunities in various business segments, including OEM and Interventional Urology, while emphasizing its strategy to drive durable growth through innovation and strategic acquisitions.
Revenue Growth in Key Segments
Teleflex reported revenues of $764.4 million, up 2.4% year-over-year on a GAAP basis and 2.2% on an adjusted constant currency basis. Interventional revenue increased 11.4% year-over-year, and Vascular Access revenue increased 6.3% year-over-year.
Palette Life Sciences Acquisition Performance
The acquisition of Palette Life Sciences is ahead of expectations, with strong revenue momentum from Barrigel. 2024 revenue guidance for Palette has been increased to $73 million to $75 million.
Gross Margin Improvement
The adjusted gross margin was 60.8% for the quarter, a 140 basis point increase versus the prior year, due to favorable impacts from the termination of the MSA and the acquisition of Palette.
Strong Cash Flow
Cash flow from operations for the first nine months was $435.6 million, a $63.2 million increase from the prior year, driven by favorable operating results and decreased cash outflows from inventories.
Expansion of Clinical Data for Titan SGS Stapler
The Titan SGS Stapler showed significant procedural efficiency and enhanced clinical outcomes in a recent study, supporting its use in laparoscopic sleeve gastrectomy.
---

Teleflex (TFX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TFX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 02, 20182018 (Q2)
- / 2.47
2.0421.08% (+0.43)
Nov 01, 20182018 (Q3)
- / 2.52
2.1218.87% (+0.40)
Feb 21, 20192018 (Q4)
- / 2.77
2.4413.52% (+0.33)
May 02, 20192019 (Q1)
- / 2.24
2.154.19% (+0.09)
Aug 01, 20192019 (Q2)
- / 2.66
2.477.69% (+0.19)
Oct 31, 20192019 (Q3)
- / 2.97
2.5217.86% (+0.45)
Feb 20, 20202019 (Q4)
- / 3.28
2.7718.41% (+0.51)
Apr 30, 20202020 (Q1)
- / 2.72
2.2421.43% (+0.48)
Jul 30, 20202020 (Q2)
- / 1.93
2.66-27.44% (-0.73)
Oct 29, 20202020 (Q3)
- / 2.77
2.97-6.73% (-0.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TFX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 31, 2024$234.80$200.70-14.52%
Aug 01, 2024$220.20$235.18+6.80%
May 02, 2024$210.51$197.76-6.06%
Feb 22, 2024$249.35$236.18-5.28%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Teleflex Inc (TFX) report earnings?
Teleflex Inc (TFX) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
    What is Teleflex Inc (TFX) earnings time?
    Teleflex Inc (TFX) earnings time is at Feb 20, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TFX EPS forecast?
          TFX EPS forecast for the fiscal quarter 2024 (Q4) is 3.86.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis